Trump, No Kings and Rhode Island
Digest more
No Kings’ protests will come to RI on Oct. 18, with marches and rallies scheduled from Providence to Block Island as part of a nationwide movement.
A tribute to lifesaving Rhode Island Hospital trauma surgeon Chuck Adams; and how Reservoir Avenue got its name.
There are more than 2,200 peaceful protests planned nationwide for Oct. 18, including nearly 25 across Rhode Island and Southeastern Massachusetts.
Rhode Island State Police said that exit ramps in downtown Providence would be intermittently closed on Oct. 18. The ramps from Route 95 North Exit 37B and South Exit 37B, and Route 6 East on Memorial Boulevard would be closed at various times.
Rhode Island State Police announced exit ramps in downtown Providence will be closed intermittently on Saturday due to a scheduled demonstration.
The Deportation Defense Network recently estimated that more than 20 people have been taken into custody by ICE outside state courthouses in Providence, Newport and at the traffic tribunal in Cranston since July.
The 212,000-square-foot building is located in the 195 District on Richmond Street. Gov. Dan McKee described the new life sciences building as the state’s “latest addition to a thriving 195 District that has put Rhode Island on the map for the life sciences industry.”
A ribbon cutting ceremony was held on Friday at a new life sciences building in Providence. The new Rhode Island Department of Health state laboratory anchors the building at 150 Richmond St. in the 195 District. The seven-story building will also be the home of Ocean State Labs, and it includes private office space.
From Gen. Nathanael Greene, to Black soldiers to everyday people, RI play key roles in the founding of America, says noted documentary filmmaker.
Members of the HIDTA Task Force arrested two men on drug charges on Oct. 17 following a narcotics investigation. Anthony Woodbury, 35, of Central Falls, was arrested and charged with possession with intent to deliver 1 ounce to 1 kilogram and possession with intent to deliver Schedule I/II drugs.